ImportRefusal LogoImportRefusal

Procaps S.A.

🚨 Critical Risk

FEI: 3008338784 • Barranquilla, Atlantico • COLOMBIA

FEI

FEI Number

3008338784

📍

Location

Barranquilla, Atlantico

🇨🇴

Country

COLOMBIA
🏢

Address

Calle 80 78b 201, , Barranquilla, Atlantico, Colombia

Critical Risk

FDA Import Risk Assessment

75.3
LowModerateHighCritical

This firm has an extensive history of FDA import refusals with severe violations.

Statistics

59
Total Refusals
6
Unique Violations
9/29/2025
Latest Refusal
2/14/2005
Earliest Refusal

Score Breakdown

Violation Severity
84.5×40%
Refusal Volume
65.9×30%
Recency
94.4×20%
Frequency
28.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7556×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1185×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

2181×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

3081×

MFR INSAN

The article is subject to refusal of admission pursuant to section 801(a)(1) in that the article appears to have been manufactured, processed, or packed under insanitary conditions.

3201×

LACKS FIRM

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.

4821×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

Refusal History

DateProductViolationsDivision
9/29/2025
62GCE90DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/3/2025
61JCA16ROSUVASTATIN CALCIUM
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/17/2025
62TCY06ESOMEPRAZOLE MAGNESIUM (ANTI-SECRETORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/13/2025
64LDK03BETAMETHASONE (GLUCOCORTICOID)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/10/2025
62GDJ90DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/24/2025
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/22/2025
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/11/2024
65KDY08LATANOPROST (PROSTAGLANDIN)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/2/2024
66JCY01LEVOTHYROXINE SODIUM (THYROID HORMONE)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/4/2024
62TDB06ESOMEPRAZOLE MAGNESIUM (ANTI-SECRETORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/12/2024
62TCC06ESOMEPRAZOLE MAGNESIUM (ANTI-SECRETORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/5/2024
61XDY45CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/19/2023
66VCA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/31/2023
54YCY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
308MFR INSAN
Division of Northern Border Imports (DNBI)
12/3/2021
62TDY06ESOMEPRAZOLE MAGNESIUM (ANTI-SECRETORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/3/2021
56YCE99ANTIBIOTIC N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/3/2021
62KCE11NITAZOXANIDE
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/12/2021
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/11/2021
60ZDA15IVERMECTIN AND COMBINATIONS (ANTIPARASITIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/26/2021
60ZCA15IVERMECTIN AND COMBINATIONS (ANTIPARASITIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/9/2020
60LDY01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/4/2020
60RDA18ORLISTAT/TETRAHYDROLIPSTATIN (ANOREXIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/4/2020
64XDA11ISOTRETINOIN (KERATOLYTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/26/2020
64XCH11ISOTRETINOIN (KERATOLYTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/22/2020
64XCF11ISOTRETINOIN (KERATOLYTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/8/2020
64XDA11ISOTRETINOIN (KERATOLYTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/18/2020
61JCA16ROSUVASTATIN CALCIUM
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/26/2020
64XDH11ISOTRETINOIN (KERATOLYTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/23/2020
61JDA08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/2/2020
64TDJ08TACROLIMUS (IMMUNOSUPPRESSIVE)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/18/2020
64XDA11ISOTRETINOIN (KERATOLYTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/26/2019
64XDA11ISOTRETINOIN (KERATOLYTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/7/2019
61BDA02CYPROTERONE ACETATE (ANTI-ANDROGEN)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/23/2019
64OCB01BELIMUMAB, MONOCLONAL ANTIBODIES
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/16/2019
56YCY99ANTIBIOTIC N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/20/2019
66VCA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/20/2019
66VCA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/30/2019
62GCA41IBUPROFEN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/13/2018
64GDY19ETHINYL ESTRADIOL (ESTROGEN)
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/30/2018
64GDB19ETHINYL ESTRADIOL (ESTROGEN)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/8/2018
56JCJ99LINCOMYCIN N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/1/2017
61PCB26METFORMIN (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/2/2017
54ABY13VITAMIN C (ASCORBIC ACID)
320LACKS FIRM
482NUTRIT LBL
Division of Southeast Imports (DSEI)
6/4/2014
64XCH11ISOTRETINOIN (KERATOLYTIC)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/30/2013
66NCF04RISPERIDONE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II)
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2012
54HIH03EVENING PRIMROSE OIL (FATS AND LIPID SUBSTANCES)
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2012
62GIA41IBUPROFEN (ANTI-INFLAMMATORY)
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2012
65PIA02SILDENAFIL CITRATE (REGULATOR)
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2012
62GIH41IBUPROFEN (ANTI-INFLAMMATORY)
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2012
60LIH01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2012
65JIH31PROGESTERONE (PROGESTIN)
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2012
61MIH41VALPROIC ACID (ANTI-CONVULSANT)
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2012
62AIH04CALCITRIOL (ANTI-HYPERCALCEMIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
9/9/2011
65JCA31PROGESTERONE (PROGESTIN)
75UNAPPROVED
New Orleans District Office (NOL-DO)
10/18/2007
61LCP99ANTI-COAGULANT, N.E.C.
118NOT LISTED
75UNAPPROVED
New Orleans District Office (NOL-DO)
5/9/2007
64XCA11ISOTRETINOIN (KERATOLYTIC)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
11/25/2005
61LCB99ANTI-COAGULANT, N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/7/2005
64HBH02GUAIFENESIN (EXPECTORANT)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/14/2005
41CYY99FOODS (INCLUDING WATER) WITH EXCESSIVE NUTRITIONAL CLAIMS
218LIST INGRE
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Procaps S.A.'s FDA import refusal history?

Procaps S.A. (FEI: 3008338784) has 59 FDA import refusal record(s) in our database, spanning from 2/14/2005 to 9/29/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Procaps S.A.'s FEI number is 3008338784.

What types of violations has Procaps S.A. received?

Procaps S.A. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Procaps S.A. come from?

All FDA import refusal data for Procaps S.A. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.